sur Hedia ApS
Hedia Gains Approval to Expand Diabetes App to Pediatric Care
Danish company Hedia has achieved a significant milestone in digital therapeutics by securing Medical Device Regulation (MDR) certification. This approval allows the expansion of their digital diabetes support to pediatric care, removing the previous age restriction of 18 and older. Parents and caregivers can now use the Hedia Diabetes Assistant for children and teenagers under 18.
The updated certification also enhances the app's capabilities to provide flexible insulin regimens and improved device connectivity. This includes support for continuous glucose monitors (CGMs), smart pens, and smart health platforms, facilitating integrated care for young patients.
Rasmus Kofoed, CEO of Hedia, emphasized the significance of this milestone, highlighting the potential for better connection between clinics and families. The approval aims to make diabetes management for children more precise and reliable, aligning with Hedia's goal of improving daily care management for families.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Hedia ApS